With a Kobe University-developed procedure, induced pluripotent stem cells can now be frozen directly in their dishes without ...

SereNeuro Therapeutics revealed promising results for SN101, a first-in-class iPSC-derived therapy designed to treat chronic ...

With a Kobe University-developed procedure, induced pluripotent stem cells can now be frozen directly in their dishes without ...

SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, unveiled new data today on ...

SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, has unveiled new data on a ...

Canine induced pluripotent stem (iPS) cells possess the ability to differentiate into any type of cell, making them a useful tool for investigating common canine diseases and disease states, including ...

Scalable iPSC neuron manufacturing advances neuroscience, improving disease modeling, therapeutic development, and clinical readiness.

Yamagami, and Amaris Castañon will discuss the latest advances and innovations in neuroscience disease cell models.

A research team has made a stem cell medium that doesn't contain any human components. E. coli was used to introduce canine ...